KR20220025912A - 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품 - Google Patents

리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품 Download PDF

Info

Publication number
KR20220025912A
KR20220025912A KR1020227004771A KR20227004771A KR20220025912A KR 20220025912 A KR20220025912 A KR 20220025912A KR 1020227004771 A KR1020227004771 A KR 1020227004771A KR 20227004771 A KR20227004771 A KR 20227004771A KR 20220025912 A KR20220025912 A KR 20220025912A
Authority
KR
South Korea
Prior art keywords
food
brain
improving agent
pantoea
lps
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020227004771A
Other languages
English (en)
Korean (ko)
Inventor
겐-이치로 소마
히로유키 이나가와
치에 코오치
유타로 고바야시
Original Assignee
시젠멘에키오요기켄 가부시키가이샤
시젠멘에키세이교기주츠켄큐쿠미아이
바이오메디칼 리서치 그룹 인코포레이티드
고쿠리츠다이가쿠호우징 카가와다이가쿠
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시젠멘에키오요기켄 가부시키가이샤, 시젠멘에키세이교기주츠켄큐쿠미아이, 바이오메디칼 리서치 그룹 인코포레이티드, 고쿠리츠다이가쿠호우징 카가와다이가쿠 filed Critical 시젠멘에키오요기켄 가부시키가이샤
Publication of KR20220025912A publication Critical patent/KR20220025912A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/739—Lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/322—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the nervous system or on mental function
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Physiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
KR1020227004771A 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품 Ceased KR20220025912A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2017105133A JP6998133B2 (ja) 2017-05-28 2017-05-28 リポ多糖を用いた脳機能改善剤、食品及び医薬品
JPJP-P-2017-105133 2017-05-28
KR1020197038343A KR20200011490A (ko) 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품
PCT/JP2017/043429 WO2018220886A1 (ja) 2017-05-28 2017-12-04 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020197038343A Division KR20200011490A (ko) 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품

Publications (1)

Publication Number Publication Date
KR20220025912A true KR20220025912A (ko) 2022-03-03

Family

ID=64455394

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020227004771A Ceased KR20220025912A (ko) 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품
KR1020197038343A Ceased KR20200011490A (ko) 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020197038343A Ceased KR20200011490A (ko) 2017-05-28 2017-12-04 리포 다당을 사용한 뇌기능 개선제, 식품 및 의약품

Country Status (8)

Country Link
US (1) US11278564B2 (https=)
EP (1) EP3643314B1 (https=)
JP (2) JP6998133B2 (https=)
KR (2) KR20220025912A (https=)
CN (1) CN110691599B (https=)
BR (1) BR112019024953A2 (https=)
IL (1) IL270936B2 (https=)
WO (1) WO2018220886A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6998133B2 (ja) * 2017-05-28 2022-01-18 自然免疫制御技術研究組合 リポ多糖を用いた脳機能改善剤、食品及び医薬品
US20220152090A1 (en) * 2020-11-13 2022-05-19 National Health Research Institutes Method for treating amyloidogenic disease
JP7679216B2 (ja) * 2021-04-07 2025-05-19 有限会社バイオメディカルリサーチグループ リポ多糖製造方法、リポ多糖、及びその配合物
JPWO2023248374A1 (https=) * 2022-06-22 2023-12-28
KR102555274B1 (ko) 2022-12-03 2023-07-13 김환배 분리형 측면 미세먼지 집진휀스로 세척이 용이한 고기구이기

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011193877A (ja) 2003-09-26 2011-10-06 Genichiro Soma 発酵及び培養方法、植物発酵エキス、植物発酵エキス末並びに該植物発酵エキス配合物
JP2016193865A (ja) 2015-03-31 2016-11-17 キリン株式会社 ミクログリア貪食活性亢進のための組成物及びミクログリア貪食活性亢進作用の予測方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2960940A1 (en) * 2014-10-02 2016-04-07 Nitto Denko Corporation Vaccine pharmaceutical composition for transdermal administration
JP6780240B2 (ja) 2015-12-11 2020-11-04 株式会社リコー 制御装置、液体を吐出する装置、印刷物の生産方法及びプログラム
JP6998133B2 (ja) * 2017-05-28 2022-01-18 自然免疫制御技術研究組合 リポ多糖を用いた脳機能改善剤、食品及び医薬品

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011193877A (ja) 2003-09-26 2011-10-06 Genichiro Soma 発酵及び培養方法、植物発酵エキス、植物発酵エキス末並びに該植物発酵エキス配合物
JP2016193865A (ja) 2015-03-31 2016-11-17 キリン株式会社 ミクログリア貪食活性亢進のための組成物及びミクログリア貪食活性亢進作用の予測方法

Non-Patent Citations (11)

* Cited by examiner, † Cited by third party
Title
C. Kohchi et al., Journal of Bioscience and Bioengineering, 102, 485-496, 2006
D. L. Herber et al., Journal of NeuroImmune Pharmacology, 2, 222-231, 2007
J. E. Morley et al., Biochimica et Biophysica Acta, 1822, 650-656, 2012
J. Hardy et al., Science, 297, 353-356, 2002
J. Mehla et al., Journal of Alzheimer's Disease, 39, 145-162, 2014
J. P. Michaud et al., Proceedings of the National Academy of Sciences of the United States of America, 110, 1941-1946, 2013
K. Nakata et al., Nutrition Research and Practice, 5, 435-442, 2011
M. Fukasaka et al., PLOS ONE, 10, e0126849, 2015
O. Westpal et al., Angewandte Chemie, 66, 407-417, 1954
Y. Ano et al., PLOS ONE, 10, e0118512, 2015
Y. Kobayashi et al., Anticancer Research, 36, 3693-3698, 2016

Also Published As

Publication number Publication date
EP3643314C0 (en) 2023-08-30
CN110691599B (zh) 2023-05-02
IL270936B2 (en) 2023-10-01
JP2021169506A (ja) 2021-10-28
BR112019024953A2 (pt) 2020-06-23
JP6998133B2 (ja) 2022-01-18
JP2018199643A (ja) 2018-12-20
JP7809461B2 (ja) 2026-02-02
EP3643314A1 (en) 2020-04-29
WO2018220886A1 (ja) 2018-12-06
EP3643314A4 (en) 2021-04-07
KR20200011490A (ko) 2020-02-03
US11278564B2 (en) 2022-03-22
EP3643314B1 (en) 2023-08-30
US20200179436A1 (en) 2020-06-11
CN110691599A (zh) 2020-01-14
IL270936B1 (en) 2023-06-01
IL270936A (en) 2020-01-30

Similar Documents

Publication Publication Date Title
JP7809461B2 (ja) リポ多糖を用いた脳機能改善剤、食品及び医薬品
US20190314425A1 (en) Akkermansia muciniphila strain having a prophylactic or therapeutic effect on a degenerative brain disease or metabolic disease and use thereof
KR101799829B1 (ko) 퇴행성 뇌질환의 예방 또는 치료 효과를 가지는 아커만시아 뮤시니필라 균주 및 이의 용도
EA025256B1 (ru) Композиция, подходящая для лечения нарушений липидного обмена
US10682322B2 (en) Supporting immunomodulatory agent
CN111032027B (zh) 使用烟酰胺核糖核苷治疗和预防运动神经元疾病
KR20200060274A (ko) 퇴행성 신경질환의 예방 또는 치료용 약학 조성물
US11096917B2 (en) Composition for preventing or treating muscle diseases, comprising suberic acid or pharmaceutically acceptable salt thereof as active ingredient
JP5769912B2 (ja) 認知障害を伴う疾患又は状態の予防又は治療用の組成物
EP3725320B1 (en) Composition comprising agathobaculum sp. strain as effective ingredient for prevention, alleviation, or treatment of autism spectrum disorder
KR102037944B1 (ko) 무메푸랄을 포함하는 인지장애 관련 질환의 예방 또는 치료용 조성물
CN109153693B (zh) 安全－稳定的缩醛磷脂和其制剂及认知症的未病状态的判断方法
HK40015331B (en) Brain function-improving agent, food, and medicine using lipopolysaccharide
HK40015331A (en) Brain function-improving agent, food, and medicine using lipopolysaccharide
JP6280356B2 (ja) 育毛・発毛促進用経口剤
US20240115530A1 (en) Administration of baiba to increase benefit of losing weight of intermittent fasting
JP7185260B2 (ja) 悪夢障害の治療用医薬組成物
Dhanalakshmi et al. Protective effect of Picrorrhiza kurroa on ochratoxin A induced oxidative stress in chickens
Jordan et al. Clinical and pathological observations on field and experimental zoalene poisoning in broiler chicks and the effect of the drug on laying hens
JP2009137856A (ja) プロリン含有抗ストレス性疾患組成物（治療剤又は予防剤）
JP2018008895A (ja) 認知機能低下抑制又は予防剤
KR20170139380A (ko) 모노아세틸디아실글리세롤 화합물을 함유하는 집중력 향상 또는 인지기능 장애 질환 예방 또는 치료용 조성물

Legal Events

Date Code Title Description
A107 Divisional application of patent
PA0104 Divisional application for international application

St.27 status event code: A-0-1-A10-A18-div-PA0104

St.27 status event code: A-0-1-A10-A16-div-PA0104

A201 Request for examination
AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

AMND Amendment
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E601 Decision to refuse application
PE0601 Decision on rejection of patent

St.27 status event code: N-2-6-B10-B15-exm-PE0601

T11-X000 Administrative time limit extension requested

St.27 status event code: U-3-3-T10-T11-oth-X000

T13-X000 Administrative time limit extension granted

St.27 status event code: U-3-3-T10-T13-oth-X000

AMND Amendment
P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PX0901 Re-examination

St.27 status event code: A-2-3-E10-E12-rex-PX0901

PX0601 Decision of rejection after re-examination

St.27 status event code: N-2-6-B10-B17-rex-PX0601

X601 Decision of rejection after re-examination